Advertisement
Canada markets closed
  • S&P/TSX

    24,822.54
    +132.06 (+0.53%)
     
  • S&P 500

    5,864.67
    +23.20 (+0.40%)
     
  • DOW

    43,275.91
    +36.86 (+0.09%)
     
  • CAD/USD

    0.7246
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    69.34
    -1.33 (-1.88%)
     
  • Bitcoin CAD

    94,165.85
    -285.52 (-0.30%)
     
  • XRP CAD

    0.75
    -0.01 (-0.73%)
     
  • GOLD FUTURES

    2,736.40
    +28.90 (+1.07%)
     
  • RUSSELL 2000

    2,276.09
    -4.76 (-0.21%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ

    18,489.55
    +115.94 (+0.63%)
     
  • VOLATILITY

    18.03
    -1.08 (-5.65%)
     
  • FTSE

    8,358.25
    -26.88 (-0.32%)
     
  • NIKKEI 225

    38,981.75
    +70.56 (+0.18%)
     
  • CAD/EUR

    0.6666
    -0.0024 (-0.36%)
     

Zoetis (ZTS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zoetis (ZTS) reported $2.04 billion in revenue for the quarter ended December 2022, representing a year-over-year increase of 3.7%. EPS of $1.15 for the same period compares to $1.00 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $2.01 billion, representing a surprise of +1.72%. The company has not delivered EPS surprise, with the consensus EPS estimate being $1.15.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Geographic Revenues-U.S.-Livestock: $259 million versus $262.15 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.5% change.

  • Geographic Revenues-U.S.-Companion Animal: $853 million versus the three-analyst average estimate of $813.12 million. The reported number represents a year-over-year change of +11.8%.

  • Geographic Revenues-International-Companion Animal: $450 million versus the three-analyst average estimate of $446.62 million. The reported number represents a year-over-year change of +7.4%.

  • Geographic Revenues-International-Livestock: $451 million compared to the $460.72 million average estimate based on three analysts. The reported number represents a change of -6.6% year over year.

  • Geographic Revenues- International Revenue: $901.30 million compared to the $907.38 million average estimate based on three analysts. The reported number represents a change of -0.1% year over year.

  • Revenues-Livestock- Sheep and other: $19 million versus the four-analyst average estimate of $20.29 million. The reported number represents a year-over-year change of -74.3%.

  • Revenues-Companion Animal: $1.30 billion compared to the $1.26 billion average estimate based on three analysts. The reported number represents a change of +10.2% year over year.

  • Revenue-Contract Manufacturing & Human Health: $27 million versus the three-analyst average estimate of $23.83 million. The reported number represents a year-over-year change of +8%.

  • Revenues-Livestock: $710 million versus $722.87 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -6.6% change.

View all Key Company Metrics for Zoetis here>>>

Shares of Zoetis have returned +1.4% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Zoetis Inc. (ZTS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research